ImageneBio, Inc.

US$4.11As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IMAHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (82.68%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM (52.87%)
Mkt cap US$46.60M
ROIC (48.44%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.13
0.65%
(89.13%)
Hold 11|11|7|1|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.07
0.07
0.07
0.08
17.25%
15.48%
18.52%
16.49%
Revenue$M
3.087
3.039
3.123
3.258
4.62%
2.25%
0.14%
4.62%
Peers (US$46.60M)
Cap (US$)
PE
46.32M
—
46.65M
10.90x
Capital
TTM
5Y
10Y
Leveragex
1.439
0.332
0.276
EBIT/Intx
0.343
1.099
1.031
Own earn%
43.71
(18.03)
(12.15)
Sh yield%
7.10
18.68
21.56
Owners
Insiders/Inst%
13.52
62.65
Short interest%
3.72
SBC / revenue%
1.58
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
2–11
$1 testx
—
Incr. ROIC%
3